TFA
GSK icon

Transamerica Financial Advisors’s GSK GSK Stock Holding History

Transamerica Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
4,132
-801
-16% -$42.4K 0.02% 404
2026
Q1 		$275K Buy
4,933
+1,053
+27% +$57.1K 0.02% 354
2025
Q4 		$191K Buy
3,880
+1,352
+53% +$63.1K 0.02% 372
2025
Q3 		$110K Sell
2,528
-2,093
-45% -$81.8K 0.01% 392
2025
Q2 		$177K Buy
4,621
+1,019
+28% +$38.9K 0.02% 232
2025
Q1 		$140K Buy
3,602
+1,843
+105% +$67.5K 0.01% 244
2024
Q4 		$60K Sell
1,759
-1,735
-50% -$62.5K 0.01% 302
2024
Q3 		$143K Buy
3,494
+3,274
+1,488% +$134K 0.01% 248
2024
Q2 		$9K Hold
220
– – ﹤0.01% 316
2024
Q1 		$10K Buy
220
+219
+21,900% +$9.03K ﹤0.01% 344
2023
Q4 		$1K Hold
1
– – ﹤0.01% 475
2023
Q3 		$1K Hold
1
– – ﹤0.01% 503
2023
Q2 		$1K Hold
1
– – ﹤0.01% 474
2023
Q1 		$1K Hold
1
– – ﹤0.01% 461
2022
Q4 		$1K Hold
1
– – ﹤0.01% 515
2022
Q3 		$1K Hold
1
– – ﹤0.01% 486
2022
Q2 		$1K Buy
+1
New +$55 ﹤0.01% 499
2016
Q2 		– Sell
-798
Closed -$41K – 520
2016
Q1 		$41K Sell
798
-723
-48% -$36K ﹤0.01% 388
2015
Q4 		$77K Hold
1,521
– – 0.01% 362
2015
Q3 		$74K Sell
1,521
-5,569
-79% -$290K 0.01% 345
2015
Q2 		$370K Sell
7,090
-371
-5% -$20.9K 0.03% 260
2015
Q1 		$431K Buy
7,461
+258
+4% +$14.8K 0.03% 245
2014
Q4 		$385K Buy
7,203
+2,245
+45% +$126K 0.03% 224
2014
Q3 		$285K Buy
4,958
+733
+17% +$44.9K 0.03% 227
2014
Q2 		$283K Buy
4,225
+100
+2% +$6.77K 0.02% 244
2014
Q1 		$276K Buy
+4,125
New +$279K 0.03% 221

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Transamerica Financial Advisors's GSK Position: Q2 2026 in Review

Transamerica Financial Advisors reduced its GSK (GSK) stake by 16% in Q2 2026, selling an estimated $42.4K and leaving 4,132 shares worth $218K. The position accounts for 0.02% of the portfolio, ranked #404.

Transamerica Financial Advisors first reported a position in GSK in Q1 2014 and has held it in 26 quarters since. The position peaked at $431K in Q1 2015. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Transamerica Financial Advisors held 4,132 shares of GSK worth $218K as of Q2 2026.
  • Transamerica Financial Advisors sold 801 GSK shares in Q2 2026, an estimated $42.4K.
  • GSK made up 0.02% of Transamerica Financial Advisors's portfolio in Q2 2026, its #404 holding.
  • Transamerica Financial Advisors first reported a position in GSK in Q1 2014 and has held it in 26 quarters since.
  • Transamerica Financial Advisors's GSK position peaked at $431K in Q1 2015.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.